Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Mary Alexander & Associates Files Second Lawsuit Against Dr. William Moore Thompson and Hoag Memorial
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Warner Bros. Discovery
-
CEEC-built World's First 300 MW Compressed Air Energy Storage Plant Connected to Grid at Full Capacity
-
Timekettle CEO Leal Tian Joins Elite Panel on AI Innovation at Microsoft's Event During CES 2025
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rentokil
-
MobileAction Enters Strategic Partnership with Skai to Enhance Apple Search Ads Capabilities
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capri Holdings
-
DeLorean Advances Its Commitment to Innovation and Engagement by Launching DMC Token
-
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENPH
-
House of Sillage Supports Los Angeles Wildfire Relief Efforts with 100% Sales Donation from Select Whispers Collection
-
Pacific Community Fund Launches Zero-Interest LA Fire Relief Fund Loan Program to Help Affected Residents and Essential Workers
-
Recor Medical Statement on CMS National Coverage Analysis of Renal Denervation for the Treatment of Hypertension
-
One Week Update: California Animal Shelters Come Together to Help People, Pets Impacted by LA Fires
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences
-
Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial
-
Vortex Metals Closes First Tranche of Non-Brokered Private Placement
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DMC
-
Sixth Street Lending Partners Announces Extension of Exchange Offer for its 6.500% Notes due 2029 and its 5.750% Notes due 2030
-
Advanced Lubrication Specialties Acquires Chemlube International LLC Lubricants Division in a Private Transaction
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Enphase Energy
-
Empowering Seniors: Caring Transitions Launches in Parsippany, NJ, Led by Tara and Brian Nielsen
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action - XRAY
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ASP Isotopes
-
ROSEN, A LEADING LAW FIRM, Encourages ASP Isotopes Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASPI
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Celsius
-
Oculus VisionTech Announces Effective Date of Name Change to Oculus Inc.
-
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
-
READOUT: SBA Administrator Guzman, FEMA Administrator Criswell Visit Los Angeles Emergency Operations Center Amid Ongoing Wildfires
-
APLT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) and Lead Plaintiff Deadline on February 18, 2025
-
Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on Februar
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
-
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
-
Nxera Pharma Provides Update on Neurocrine’s Progress with its Partnered Muscarinic Agonist Portfolio
-
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
-
TSA publishes final rule on REAL ID enforcement beginning May 7, 2025
-
Teladoc Health Joins Amazon’s Health Benefits Connector for Cardiometabolic Programs
-
Sony Group Announces $5 Million Donation to Support Southern California Wildfire Emergency Relief and Rebuilding Efforts
-
CN Bio Signs Strategic Partnership With Primetech Corporation to Establish Distribution Channel for OOC Solutions in Japan
-
Sturgeon Public School Strike to Escalate
-
Cipher Protocol: A Game-Changer in Privacy, AI, and Blockchain Scalability
-
STACK Infrastructure Announces 220MW Campus in Malaysia
-
Red Rock Resorts Announces Date of Fourth Quarter and Full Year 2024 Conference Call and Earnings Release Date
-
ROSS STORES DONATES $850,000 FOR DISASTER RELIEF AND RECOVERY IN RESPONSE TO CALIFORNIA WILDFIRES
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte
-
RecycLiCo Interim CEO Releases Letter to Shareholders
-
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Match Group
-
Teck Announces Appointment of Colin Hamilton as Vice President, Market Research and Economic Analysis
-
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Intra-Cellular Therapies, Inc. Buyout
-
Choice Properties Real Estate Investment Trust Announces Issuance of $300 million of Series V Senior Unsecured Debentures
